Vaccine Oxford, AstraZeneca: we can still do it by the end of the year
Oxford agreement and AstraZeneca anti-covid vaccine, non-profit model for the duration of the pandemic
Coronavirus: AstraZeneca resumes vaccine testing in Great Britain
Coronavirus, Ema starts evaluation of the Oxford-AstraZeneca vaccine
Share
October 23, 2020The Food and Drug Administration, the American federal agency for drug safety, has decided to allow tests for the vaccine candidate developed by AstraZeneca and the University of Oxford to resume in the US. The Wall Street Journal writes it.
The FDA made its decision after examining two cases of possible neurological side effect linked to as many volunteers: the agency did not find that the vaccine was responsible for the two cases, although it could not rule out a link, according to a source. of the Wsj.